Mogidonto and Boutique Dental have been acquired by OdontoPrev
The owner of Mogidonto and Boutique Dental has sold the companies to OdontoPrev.
Founded in 1976 in Mogi das Cruzes, Brazil, Mogidonto is a vertical operator of private dental care plans, with more than 62,000 beneficiaries. It has its own service network, Boutique Dental, which has three units located in Mogi das Cruzes, Itaquaquecetuba and Suzano. Boutique Dental units perform more than 15,000 consultations per month and have 24-hour urgent and emergency care services. In addition to its own units, Mogidonto has a network of more than 650 accredited dentists in Brazil.
OdontoPrev, a publicly traded company since 2006, is the leader in dental plans in Latin America, with more than 7.5 million beneficiaries. The company has a network of dental surgeons with approximately 31,000 professionals in Brazil. The acquisition of Mogidonto and Boutique Dental consolidates OdontoPrev as the leader in the Alto Tietê region and reinforces its strategy to improve control over dental plan usage. OdontoPrev acquired Boutique Dental through its subsidiary, Clidec.
One of Oaklins’ teams in Brazil acted as lead advisor to the seller and the management of Mogidonto and Boutique Dental in the preparation of the sale process and due diligence, the approach and parallel negotiations with potential buyers, and assisted them until closing.
Talk to the deal team
Denis Morante
Oaklins Fortezza Partners
Related deals
Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.
Learn moreRare Patient Voice has been acquired by Konovo
Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.
Learn moreLindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.
Learn more